| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contraception | 25 | 2022 | 88 | 9.080 |
Why?
|
| Abortion, Induced | 20 | 2022 | 120 | 8.630 |
Why?
|
| Contraception Behavior | 14 | 2018 | 26 | 5.550 |
Why?
|
| Contraceptive Agents, Female | 16 | 2022 | 31 | 5.300 |
Why?
|
| Health Knowledge, Attitudes, Practice | 15 | 2020 | 508 | 4.330 |
Why?
|
| Intrauterine Devices | 11 | 2017 | 28 | 4.120 |
Why?
|
| Pregnancy | 52 | 2022 | 2894 | 3.770 |
Why?
|
| Family Planning Services | 10 | 2022 | 36 | 3.530 |
Why?
|
| Adolescent Behavior | 8 | 2020 | 106 | 3.110 |
Why?
|
| Counseling | 9 | 2020 | 145 | 3.010 |
Why?
|
| Pregnancy in Adolescence | 9 | 2020 | 25 | 2.960 |
Why?
|
| Adolescent | 55 | 2022 | 8981 | 2.560 |
Why?
|
| Sexual Behavior | 13 | 2021 | 302 | 2.460 |
Why?
|
| Health Services Accessibility | 10 | 2020 | 394 | 2.010 |
Why?
|
| Female | 95 | 2022 | 44532 | 2.000 |
Why?
|
| Poverty | 6 | 2020 | 173 | 1.970 |
Why?
|
| Chicago | 23 | 2021 | 1379 | 1.970 |
Why?
|
| Sexual Partners | 7 | 2018 | 93 | 1.910 |
Why?
|
| Communication | 6 | 2019 | 441 | 1.870 |
Why?
|
| Pregnancy, Unplanned | 9 | 2019 | 18 | 1.760 |
Why?
|
| Ambulatory Care Facilities | 5 | 2018 | 102 | 1.750 |
Why?
|
| Intrauterine Devices, Medicated | 4 | 2021 | 12 | 1.720 |
Why?
|
| Young Adult | 33 | 2020 | 5976 | 1.720 |
Why?
|
| Social Support | 6 | 2020 | 193 | 1.700 |
Why?
|
| Doulas | 3 | 2018 | 7 | 1.680 |
Why?
|
| Patient Satisfaction | 10 | 2016 | 455 | 1.660 |
Why?
|
| Mobile Applications | 3 | 2018 | 63 | 1.650 |
Why?
|
| Sexually Transmitted Diseases | 6 | 2018 | 91 | 1.580 |
Why?
|
| Long-Acting Reversible Contraception | 2 | 2022 | 10 | 1.530 |
Why?
|
| Sex Education | 5 | 2015 | 9 | 1.510 |
Why?
|
| Humans | 100 | 2022 | 86643 | 1.460 |
Why?
|
| Abortion, Legal | 4 | 2020 | 25 | 1.430 |
Why?
|
| Reproductive Health Services | 3 | 2018 | 20 | 1.410 |
Why?
|
| Social Stigma | 2 | 2020 | 52 | 1.410 |
Why?
|
| Condoms | 7 | 2018 | 36 | 1.410 |
Why?
|
| Postpartum Period | 5 | 2015 | 135 | 1.400 |
Why?
|
| Attitude to Health | 3 | 2018 | 220 | 1.370 |
Why?
|
| Patient Education as Topic | 6 | 2019 | 351 | 1.250 |
Why?
|
| Adult | 44 | 2021 | 25648 | 1.240 |
Why?
|
| Games, Recreational | 2 | 2018 | 3 | 1.220 |
Why?
|
| Contraceptive Devices, Female | 7 | 2019 | 9 | 1.180 |
Why?
|
| Qualitative Research | 9 | 2021 | 256 | 1.140 |
Why?
|
| Levonorgestrel | 4 | 2021 | 11 | 1.110 |
Why?
|
| Motivational Interviewing | 2 | 2016 | 18 | 1.090 |
Why?
|
| Contraceptives, Oral | 4 | 2015 | 46 | 1.070 |
Why?
|
| Interpersonal Relations | 6 | 2018 | 170 | 1.030 |
Why?
|
| Focus Groups | 7 | 2021 | 155 | 1.020 |
Why?
|
| Social Justice | 2 | 2020 | 49 | 1.020 |
Why?
|
| Parents | 4 | 2014 | 272 | 0.980 |
Why?
|
| Internet | 2 | 2018 | 312 | 0.970 |
Why?
|
| Sexual Health | 2 | 2021 | 14 | 0.960 |
Why?
|
| Parent-Child Relations | 3 | 2014 | 77 | 0.960 |
Why?
|
| Interviews as Topic | 9 | 2018 | 319 | 0.960 |
Why?
|
| Coitus Interruptus | 3 | 2019 | 3 | 0.950 |
Why?
|
| Prenatal Care | 2 | 2019 | 72 | 0.910 |
Why?
|
| Students | 3 | 2015 | 147 | 0.900 |
Why?
|
| Cesarean Section | 3 | 2021 | 137 | 0.880 |
Why?
|
| Menstruation | 2 | 2020 | 30 | 0.860 |
Why?
|
| Insurance Coverage | 3 | 2019 | 117 | 0.860 |
Why?
|
| Sterilization, Tubal | 3 | 2007 | 11 | 0.850 |
Why?
|
| Physician-Patient Relations | 2 | 2019 | 610 | 0.850 |
Why?
|
| Postnatal Care | 3 | 2013 | 25 | 0.840 |
Why?
|
| Attitude | 3 | 2018 | 127 | 0.830 |
Why?
|
| Developing Countries | 3 | 2012 | 71 | 0.830 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 66 | 0.830 |
Why?
|
| Social Media | 2 | 2014 | 79 | 0.820 |
Why?
|
| Body Image | 1 | 2021 | 76 | 0.800 |
Why?
|
| Urban Population | 4 | 2016 | 213 | 0.800 |
Why?
|
| Health Expenditures | 2 | 2019 | 86 | 0.770 |
Why?
|
| Insurance, Health | 2 | 2019 | 160 | 0.750 |
Why?
|
| Surveys and Questionnaires | 11 | 2020 | 2501 | 0.750 |
Why?
|
| Research | 1 | 2021 | 253 | 0.740 |
Why?
|
| Exposure to Violence | 1 | 2020 | 12 | 0.740 |
Why?
|
| Reproductive Medicine | 2 | 2011 | 9 | 0.740 |
Why?
|
| Sterilization, Reproductive | 4 | 2019 | 12 | 0.730 |
Why?
|
| Mexican Americans | 2 | 2010 | 63 | 0.690 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 160 | 0.680 |
Why?
|
| Tobacco Industry | 1 | 2018 | 7 | 0.670 |
Why?
|
| Medication Adherence | 2 | 2010 | 129 | 0.670 |
Why?
|
| Pregnancy Trimester, First | 6 | 2018 | 63 | 0.660 |
Why?
|
| Tobacco Use | 1 | 2018 | 24 | 0.660 |
Why?
|
| Pilot Projects | 6 | 2020 | 839 | 0.660 |
Why?
|
| Aftercare | 1 | 2019 | 85 | 0.660 |
Why?
|
| Rural Population | 2 | 2016 | 136 | 0.650 |
Why?
|
| Mobile Health Units | 1 | 2018 | 11 | 0.650 |
Why?
|
| Social Networking | 1 | 2019 | 75 | 0.650 |
Why?
|
| Contraceptive Agents | 3 | 2022 | 20 | 0.640 |
Why?
|
| Volunteers | 1 | 2018 | 19 | 0.630 |
Why?
|
| Abortion Applicants | 2 | 2020 | 6 | 0.630 |
Why?
|
| Health Equity | 1 | 2020 | 77 | 0.630 |
Why?
|
| Contraceptives, Postcoital | 3 | 2022 | 5 | 0.620 |
Why?
|
| Refugees | 1 | 2017 | 6 | 0.620 |
Why?
|
| Health Services | 1 | 2018 | 55 | 0.620 |
Why?
|
| Gender Identity | 1 | 2018 | 52 | 0.620 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2020 | 238 | 0.620 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2018 | 66 | 0.610 |
Why?
|
| Contraceptives, Oral, Hormonal | 3 | 2019 | 18 | 0.600 |
Why?
|
| User-Computer Interface | 1 | 2018 | 185 | 0.590 |
Why?
|
| Health Care Reform | 1 | 2018 | 90 | 0.590 |
Why?
|
| United States | 17 | 2020 | 6672 | 0.590 |
Why?
|
| Contraception, Postcoital | 2 | 2019 | 8 | 0.570 |
Why?
|
| Patient Participation | 3 | 2007 | 216 | 0.570 |
Why?
|
| Contraceptive Devices | 2 | 2022 | 5 | 0.550 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2012 | 21 | 0.540 |
Why?
|
| Health Promotion | 2 | 2014 | 160 | 0.540 |
Why?
|
| Parental Notification | 2 | 2012 | 7 | 0.530 |
Why?
|
| Fathers | 2 | 2014 | 70 | 0.530 |
Why?
|
| Motivation | 1 | 2018 | 287 | 0.530 |
Why?
|
| Desogestrel | 2 | 2012 | 2 | 0.530 |
Why?
|
| Mothers | 2 | 2014 | 141 | 0.520 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 12 | 0.510 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2014 | 25 | 0.510 |
Why?
|
| Women's Health | 2 | 2016 | 100 | 0.500 |
Why?
|
| Premature Birth | 1 | 2015 | 113 | 0.480 |
Why?
|
| Appointments and Schedules | 1 | 2014 | 53 | 0.480 |
Why?
|
| Video Recording | 1 | 2014 | 190 | 0.470 |
Why?
|
| Reproductive Health | 3 | 2021 | 32 | 0.460 |
Why?
|
| Referral and Consultation | 1 | 2016 | 328 | 0.460 |
Why?
|
| Role | 1 | 2012 | 11 | 0.450 |
Why?
|
| Infant Welfare | 1 | 2012 | 6 | 0.440 |
Why?
|
| Maternal Welfare | 1 | 2012 | 9 | 0.440 |
Why?
|
| Maternal Mortality | 1 | 2012 | 15 | 0.440 |
Why?
|
| Logistic Models | 6 | 2015 | 1186 | 0.440 |
Why?
|
| Male | 19 | 2018 | 40965 | 0.440 |
Why?
|
| Infant Mortality | 1 | 2012 | 59 | 0.430 |
Why?
|
| Telecommunications | 1 | 2012 | 7 | 0.430 |
Why?
|
| Decision Making | 5 | 2019 | 642 | 0.420 |
Why?
|
| Parity | 4 | 2021 | 93 | 0.410 |
Why?
|
| Vacuum Curettage | 2 | 2009 | 5 | 0.410 |
Why?
|
| Illinois | 6 | 2012 | 462 | 0.400 |
Why?
|
| Feasibility Studies | 3 | 2020 | 751 | 0.400 |
Why?
|
| Curriculum | 1 | 2015 | 539 | 0.390 |
Why?
|
| Minors | 1 | 2010 | 15 | 0.380 |
Why?
|
| World Health Organization | 1 | 2011 | 103 | 0.380 |
Why?
|
| Parental Consent | 1 | 2010 | 35 | 0.380 |
Why?
|
| Family | 2 | 2014 | 311 | 0.380 |
Why?
|
| Intention | 1 | 2010 | 51 | 0.370 |
Why?
|
| Physicians | 1 | 2018 | 673 | 0.370 |
Why?
|
| Culture | 2 | 2007 | 53 | 0.370 |
Why?
|
| Intrauterine Devices, Copper | 1 | 2009 | 3 | 0.360 |
Why?
|
| Schools | 3 | 2018 | 71 | 0.360 |
Why?
|
| Risk-Taking | 3 | 2020 | 148 | 0.360 |
Why?
|
| Social Environment | 2 | 2021 | 188 | 0.360 |
Why?
|
| Ethinyl Estradiol | 3 | 2019 | 16 | 0.360 |
Why?
|
| Women's Health Services | 1 | 2009 | 15 | 0.360 |
Why?
|
| Dilatation and Curettage | 1 | 2009 | 3 | 0.350 |
Why?
|
| Emotions | 3 | 2018 | 341 | 0.350 |
Why?
|
| Health Services Needs and Demand | 3 | 2020 | 102 | 0.340 |
Why?
|
| Intention to Treat Analysis | 3 | 2014 | 72 | 0.330 |
Why?
|
| Pregnancy, Unwanted | 1 | 2008 | 4 | 0.330 |
Why?
|
| Publishing | 1 | 2009 | 90 | 0.330 |
Why?
|
| Pregnant Women | 2 | 2019 | 35 | 0.330 |
Why?
|
| Psychology, Adolescent | 1 | 2008 | 29 | 0.330 |
Why?
|
| Contraceptives, Oral, Combined | 2 | 2007 | 8 | 0.320 |
Why?
|
| Tramadol | 1 | 2007 | 14 | 0.310 |
Why?
|
| Ibuprofen | 1 | 2007 | 28 | 0.310 |
Why?
|
| Coitus | 1 | 2007 | 20 | 0.310 |
Why?
|
| Multivariate Analysis | 4 | 2014 | 999 | 0.310 |
Why?
|
| Adolescent Health Services | 1 | 2007 | 11 | 0.310 |
Why?
|
| Peer Group | 1 | 2007 | 72 | 0.300 |
Why?
|
| Nonprescription Drugs | 1 | 2006 | 15 | 0.290 |
Why?
|
| Norpregnadienes | 2 | 2022 | 7 | 0.290 |
Why?
|
| Teaching | 1 | 2008 | 147 | 0.290 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 567 | 0.290 |
Why?
|
| Drug Approval | 1 | 2006 | 62 | 0.280 |
Why?
|
| Age Factors | 5 | 2014 | 1851 | 0.280 |
Why?
|
| Office Visits | 2 | 2019 | 44 | 0.280 |
Why?
|
| Obesity | 1 | 2012 | 963 | 0.260 |
Why?
|
| Maternal Health Services | 1 | 2005 | 16 | 0.260 |
Why?
|
| Pain | 1 | 2007 | 391 | 0.260 |
Why?
|
| Risk Factors | 6 | 2019 | 5417 | 0.250 |
Why?
|
| Universities | 3 | 2010 | 135 | 0.250 |
Why?
|
| Longitudinal Studies | 5 | 2020 | 1019 | 0.250 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 1621 | 0.240 |
Why?
|
| Patient Compliance | 2 | 2008 | 227 | 0.240 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 336 | 0.230 |
Why?
|
| Cultural Characteristics | 2 | 2017 | 19 | 0.230 |
Why?
|
| Violence | 2 | 2020 | 143 | 0.230 |
Why?
|
| Mental Recall | 1 | 2004 | 159 | 0.220 |
Why?
|
| Placenta Previa | 1 | 2002 | 3 | 0.220 |
Why?
|
| Cesarean Section, Repeat | 1 | 2002 | 3 | 0.220 |
Why?
|
| Urban Health Services | 2 | 2016 | 45 | 0.210 |
Why?
|
| Single-Blind Method | 2 | 2014 | 153 | 0.210 |
Why?
|
| Child | 5 | 2020 | 6927 | 0.210 |
Why?
|
| Drug Implants | 2 | 2014 | 34 | 0.200 |
Why?
|
| Needs Assessment | 1 | 2022 | 154 | 0.200 |
Why?
|
| Contraceptive Devices, Male | 1 | 2000 | 1 | 0.200 |
Why?
|
| Cohort Studies | 5 | 2020 | 2767 | 0.200 |
Why?
|
| Menopause | 1 | 2001 | 71 | 0.200 |
Why?
|
| Social Control Policies | 1 | 2020 | 2 | 0.200 |
Why?
|
| Hormone Replacement Therapy | 1 | 2001 | 77 | 0.190 |
Why?
|
| India | 1 | 2020 | 120 | 0.190 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 3640 | 0.180 |
Why?
|
| Pregnenediones | 1 | 2019 | 8 | 0.170 |
Why?
|
| Stakeholder Participation | 1 | 2019 | 19 | 0.170 |
Why?
|
| Odds Ratio | 2 | 2014 | 678 | 0.170 |
Why?
|
| Transportation | 1 | 2018 | 18 | 0.160 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 203 | 0.160 |
Why?
|
| Men | 1 | 2018 | 10 | 0.160 |
Why?
|
| Interinstitutional Relations | 1 | 2018 | 28 | 0.160 |
Why?
|
| Self Efficacy | 1 | 2018 | 53 | 0.160 |
Why?
|
| Somalia | 1 | 2017 | 1 | 0.160 |
Why?
|
| Eritrea | 1 | 2017 | 1 | 0.160 |
Why?
|
| Research Design | 1 | 2021 | 594 | 0.160 |
Why?
|
| Ethiopia | 1 | 2017 | 37 | 0.160 |
Why?
|
| Time Factors | 3 | 2013 | 5210 | 0.150 |
Why?
|
| Birth Rate | 1 | 2017 | 12 | 0.150 |
Why?
|
| Poverty Areas | 2 | 2007 | 37 | 0.150 |
Why?
|
| Social Work | 1 | 2017 | 19 | 0.150 |
Why?
|
| Program Development | 1 | 2018 | 124 | 0.150 |
Why?
|
| Choice Behavior | 1 | 2018 | 160 | 0.150 |
Why?
|
| Quality of Health Care | 2 | 2012 | 380 | 0.150 |
Why?
|
| Hospitals, Urban | 2 | 2013 | 54 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2018 | 297 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2015 | 2261 | 0.140 |
Why?
|
| Perception | 1 | 2017 | 168 | 0.140 |
Why?
|
| Contraceptive Prevalence Surveys | 1 | 2016 | 1 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 454 | 0.140 |
Why?
|
| Rural Health Services | 1 | 2016 | 13 | 0.140 |
Why?
|
| Confidentiality | 1 | 2016 | 78 | 0.140 |
Why?
|
| Midwestern United States | 1 | 2016 | 76 | 0.140 |
Why?
|
| Public Health | 1 | 2017 | 129 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 202 | 0.140 |
Why?
|
| Societies | 1 | 2015 | 12 | 0.140 |
Why?
|
| Michigan | 1 | 2015 | 52 | 0.130 |
Why?
|
| Sexuality | 1 | 2015 | 40 | 0.130 |
Why?
|
| Drug Combinations | 2 | 2019 | 224 | 0.130 |
Why?
|
| Psychological Theory | 1 | 2014 | 22 | 0.130 |
Why?
|
| Administration, Cutaneous | 2 | 2007 | 58 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2012 | 8489 | 0.130 |
Why?
|
| Nuclear Family | 1 | 2014 | 92 | 0.130 |
Why?
|
| Marital Status | 2 | 2012 | 40 | 0.120 |
Why?
|
| Text Messaging | 1 | 2014 | 27 | 0.120 |
Why?
|
| Telephone | 1 | 2014 | 32 | 0.120 |
Why?
|
| Gynecology | 1 | 2016 | 124 | 0.120 |
Why?
|
| Intrauterine Device Expulsion | 1 | 2013 | 2 | 0.120 |
Why?
|
| Tooth Abnormalities | 1 | 1994 | 6 | 0.120 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2013 | 20 | 0.120 |
Why?
|
| Lost to Follow-Up | 1 | 2013 | 12 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 98 | 0.120 |
Why?
|
| Delayed-Action Preparations | 2 | 2012 | 116 | 0.120 |
Why?
|
| Supreme Court Decisions | 1 | 2013 | 9 | 0.120 |
Why?
|
| Medical Records | 2 | 2005 | 119 | 0.110 |
Why?
|
| Health Surveys | 1 | 2014 | 239 | 0.110 |
Why?
|
| B7 Antigens | 1 | 2012 | 5 | 0.110 |
Why?
|
| Placentation | 1 | 2012 | 11 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 636 | 0.110 |
Why?
|
| Leisure Activities | 1 | 2012 | 8 | 0.110 |
Why?
|
| HLA-G Antigens | 1 | 2012 | 52 | 0.110 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 17 | 0.110 |
Why?
|
| Residence Characteristics | 2 | 2012 | 197 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2014 | 247 | 0.110 |
Why?
|
| Health Plan Implementation | 1 | 2012 | 56 | 0.110 |
Why?
|
| Evaluation Studies as Topic | 1 | 2012 | 274 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 153 | 0.100 |
Why?
|
| Exosomes | 1 | 2012 | 50 | 0.100 |
Why?
|
| Abortifacient Agents | 1 | 2011 | 2 | 0.100 |
Why?
|
| Social Conditions | 1 | 2011 | 8 | 0.100 |
Why?
|
| Nigeria | 1 | 2012 | 152 | 0.100 |
Why?
|
| Hospitals, University | 2 | 2012 | 194 | 0.100 |
Why?
|
| Area Under Curve | 1 | 2012 | 334 | 0.100 |
Why?
|
| Health Policy | 1 | 2013 | 180 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2012 | 170 | 0.100 |
Why?
|
| Placenta | 1 | 2012 | 175 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 379 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 859 | 0.100 |
Why?
|
| Acculturation | 1 | 2010 | 14 | 0.100 |
Why?
|
| Health Communication | 1 | 2010 | 13 | 0.100 |
Why?
|
| B7-H1 Antigen | 1 | 2012 | 250 | 0.100 |
Why?
|
| Employment | 1 | 2010 | 52 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 111 | 0.090 |
Why?
|
| Public Policy | 1 | 2010 | 52 | 0.090 |
Why?
|
| Educational Status | 1 | 2010 | 188 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 364 | 0.090 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2009 | 6 | 0.090 |
Why?
|
| Norethindrone | 1 | 2009 | 12 | 0.090 |
Why?
|
| Forecasting | 1 | 2010 | 304 | 0.090 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2009 | 103 | 0.090 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2008 | 9 | 0.080 |
Why?
|
| Gonorrhea | 1 | 2008 | 18 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2008 | 25 | 0.080 |
Why?
|
| Sexual Abstinence | 1 | 2008 | 10 | 0.080 |
Why?
|
| Rape | 1 | 2008 | 17 | 0.080 |
Why?
|
| Global Health | 1 | 2009 | 193 | 0.080 |
Why?
|
| Menstruation Disturbances | 1 | 2008 | 24 | 0.080 |
Why?
|
| Abortion, Therapeutic | 1 | 2007 | 11 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2009 | 221 | 0.080 |
Why?
|
| Safe Sex | 1 | 2008 | 23 | 0.080 |
Why?
|
| Medicaid | 2 | 2012 | 217 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 865 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2010 | 313 | 0.080 |
Why?
|
| Professional-Patient Relations | 1 | 2007 | 53 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 584 | 0.070 |
Why?
|
| Personal Autonomy | 1 | 2007 | 112 | 0.070 |
Why?
|
| Cultural Diversity | 1 | 2007 | 51 | 0.070 |
Why?
|
| Fetal Death | 1 | 2006 | 56 | 0.070 |
Why?
|
| Analgesics | 1 | 2007 | 119 | 0.070 |
Why?
|
| Administration, Intravaginal | 2 | 2008 | 7 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2379 | 0.070 |
Why?
|
| Community Health Centers | 1 | 2007 | 113 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2006 | 127 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1673 | 0.070 |
Why?
|
| Elective Surgical Procedures | 1 | 2006 | 116 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2008 | 7993 | 0.070 |
Why?
|
| Puerto Rico | 1 | 2004 | 31 | 0.060 |
Why?
|
| Mexico | 1 | 2004 | 67 | 0.060 |
Why?
|
| Pregnancy Rate | 1 | 2004 | 20 | 0.060 |
Why?
|
| Videotape Recording | 1 | 2004 | 47 | 0.060 |
Why?
|
| Middle Aged | 3 | 2017 | 25028 | 0.060 |
Why?
|
| Health Education | 1 | 2004 | 101 | 0.060 |
Why?
|
| Mass Screening | 1 | 2008 | 618 | 0.060 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 141 | 0.060 |
Why?
|
| Language | 1 | 2004 | 151 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 744 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2232 | 0.050 |
Why?
|
| Ovulation Inhibition | 1 | 2022 | 3 | 0.050 |
Why?
|
| Ovulation | 1 | 2022 | 68 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2010 | 4213 | 0.050 |
Why?
|
| Progesterone | 1 | 2022 | 110 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2002 | 112 | 0.050 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2001 | 16 | 0.050 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2001 | 34 | 0.050 |
Why?
|
| Spermatocidal Agents | 1 | 2000 | 1 | 0.050 |
Why?
|
| Condoms, Female | 1 | 2000 | 2 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2020 | 71 | 0.050 |
Why?
|
| Quality of Life | 1 | 2009 | 1585 | 0.050 |
Why?
|
| Income | 1 | 2020 | 75 | 0.050 |
Why?
|
| Travel | 1 | 2020 | 68 | 0.050 |
Why?
|
| Propensity Score | 1 | 2020 | 136 | 0.050 |
Why?
|
| HIV Infections | 1 | 2008 | 772 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1805 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2011 | 3612 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2015 | 175 | 0.030 |
Why?
|
| Radiography, Panoramic | 1 | 1994 | 7 | 0.030 |
Why?
|
| Tetraspanin 30 | 1 | 2012 | 3 | 0.030 |
Why?
|
| Politics | 1 | 2013 | 50 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 11 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2012 | 33 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2012 | 70 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2012 | 23 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 79 | 0.030 |
Why?
|
| Urban Health | 1 | 2012 | 55 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2011 | 21 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 270 | 0.030 |
Why?
|
| Organ Size | 1 | 2011 | 364 | 0.020 |
Why?
|
| Gonadotropins | 1 | 2009 | 34 | 0.020 |
Why?
|
| Prevalence | 1 | 1994 | 1239 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2009 | 44 | 0.020 |
Why?
|
| Integrases | 1 | 2009 | 59 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 303 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 128 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 154 | 0.020 |
Why?
|
| Estrogens | 1 | 2009 | 200 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2011 | 548 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 782 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 552 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 1041 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2818 | 0.020 |
Why?
|
| Biomarkers | 1 | 2012 | 1718 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 1924 | 0.020 |
Why?
|
| Aged | 1 | 2001 | 18415 | 0.020 |
Why?
|
| Apoptosis | 1 | 2009 | 1683 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 11352 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 26582 | 0.010 |
Why?
|